Where can I buy Amgen stock?
Shares of AMGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Amgen's stock price today?
How many insiders own Amgen (AMGN)?
Only 0.36% of the stock of Amgen is held by insiders. 74.95% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Amgen are expected to grow by 6.95% in the coming year, from $16.83 to $18.00 per share.
What are analysts'1 year price targets for Amgen's stock?
20 analysts have issued 1 year price objectives for Amgen's stock. Their predictions range from $189.00 to $243.00. On average, they expect Amgen's stock price to reach $217.29 in the next twelve months. This suggests a possible upside of 6.9% from the stock's current price.
What is the circulating supply of Amgen (AMG)?
The circulating supply is not available and a max. supply of 99,000,000 AMG coins. If you would like to know where to buy Amgen at the current rate, the top cryptocurrency exchange for trading in Amgen stock is currently PancakeSwap (V2). You can find others listed on our crypto exchanges page.
See more
Is Amgen a buy sell or hold?
Amgen has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 3 buy ratings, 10 hold ratings, and 1 sell rating.
Is Amgen a good buy?
Amgen Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AMGN, demonstrate its potential to outperform the market. It currently has a Growth Score of A.
Is Amgen profitable?
Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amgen net profit margin as of March 31, 2022 is 21.75%....Compare AMGN With Other Stocks.Stock NameSQZ Biotechnologies (SQZ)CountryUnited StatesMarket Cap$0.087BPE Ratio0.0013 more columns
How much is Amgen?
$ 245.56CloseChgChg %$245.78-0.85-0.34%
Is AMGN a buy now?
Out of 14 analysts, 2 (14.29%) are recommending AMGN as a Strong Buy, 1 (7.14%) are recommending AMGN as a Buy, 11 (78.57%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 0 (0%) are recommending AMGN as a Strong Sell.
Is Amgen stock going to split?
Amgen (AMGN) has 5 splits in our Amgen stock split history database. The first split for AMGN took place on August 13, 1990....AMGN Split History TableDateRatio11/22/19992 for 14 more rows
How often does Amgen pay dividends?
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 4.7. Our premium tools have predicted AMGEN Inc. with 99% accuracy.
Who is Amgen's biggest competitor?
Amgen competitors include Merck, Genentech, MedImmune, Genzyme and Celgene. Amgen ranks 1st in Gender Score on Comparably vs its competitors. See below how Amgen compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Is Amgen growing?
Amgen is projecting compound annual growth in mid-single digits through the end of this decade. Considering the company reported 2021 revenue at $26 billion, that level of growth would get Amgen to roughly $35 billion in revenue in 2030.
Is Amgen a stable company?
Amgen is a very good company to work for if you are looking for very good benefits and salary. Benefits, pay, culture, professionalism. Some of the best time off of any company in the biotechnology industry. Unstable environment at the present.
What happened today Amgen?
Amgen (AMGN) closed the most recent trading day at $246.73, moving +0.48% from the previous trading session.
What is Amgen best known for?
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
How much does Amgen make?
When is Amgen earnings call?
Amgen has a market capitalization of $140.58 billion and generates $25.42 billion in revenue each year. The medical research company earns $7.26 billion in net income (profit) each year or $16.60 on an earnings per share basis.
What is the dividend payout ratio of Amgen?
How can I listen to Amgen's earnings call? Amgen will be holding an earnings conference call on Tuesday, August 3rd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "1682169".
Where is Amgen headquartered?
Amgen does not yet have a strong track record of dividend growth. The dividend payout ratio of Amgen is 42.41%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amgen will have a dividend payout ratio of 39.09% next year.
What is the Amgen valuation method?
Listed exchange for this security. NASDAQ. About. . . Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks , California, in 1980.
What is Amgen Inc?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
What is the name of the drug that Amgen makes for cancer?
About Amgen Inc. Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases.
What time does AMC stock trade?
Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acq.
Does market cap include convertible securities?
AMC Entertainment Holdings, Inc. Class A Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
Sales
Risks
- 17 Wall Street analysts have issued 12 month price objectives for Amgen's stock. Their forecasts range from $179.00 to $232.00. On average, they anticipate Amgen's share price to reach $207.4706 in the next year. This suggests a possible upside of 20.7% from the stock's current price. View Analyst Price Targets for Amgen.
Ratings
- 17 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Amgen in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of \"Hold.\" View Analyst Ratings for Amgen.
Reception
- Media stories about AMGN stock have trended somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most f…
Ownership
- Amgen's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.56%), Wells Fargo & Company MN (1.23%), LSV Asset Management (0.64%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), Dimensional Fund Advisors LP (0.39%) and Parametric Portfolio Associates LLC (0.38%). Company insiders that own Amge…
Business
- Amgen has a market capitalization of $104.82 billion and generates $23.75 billion in revenue each year. The medical research company earns $8.39 billion in net income (profit) each year or $14.40 on an earnings per share basis. Amgen employs 21,500 workers across the globe.
Infrastructure
- Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company can be reached via phone at 805-447-1000 or via email at [email protected].